Pharmaceutical Serialization Mandates Keep Expanding Globally
The United States Drug Supply Chain Security Act, the European Union's Falsified Medicines Directive, and India's staggered national serialization rules have progressively required pharmaceutical packaging to carry unique, traceable identifiers readable at each point in the distribution chain. Additional countries across Southeast Asia, Latin America, and the Middle East are adopting comparable requirements on rolling implementation timelines through 2030, creating a predictable multi-year demand pipeline for RFID and serialized label technology. Manufacturers report multi-year order backlogs for compliant packaging lines as pharmaceutical companies race to meet deadlines rather than risk shipment holds or market access restrictions in regulated jurisdictions specifically.
Market Impact: Cuts RFID unit costs 30%








